Higher Doses of Upadacitinib Increase Rate of Serious Infections
The incidence rate of serious infection events and opportunistic infections was higher among the upadacitinib 30 mg group than the 15 mg group.
Netakimab Rapidly Improves Axial Disease
The findings are based on data from a 24-week observation from an ongoing phase 3 PATERA study.
Nanoparticle Treatment Showing Promise Against Rheumatoid Arthritis
In a late-breaking abstract, investigators test nanoparticle treatment using in vivo models.
Positive Results Treating Active Psoriatic Arthritis with Upadacitinib
In an abstract presented at EULAR 2020, investigators find more serious adverse events in the upadacitinib treatment arms compared to placebo.
Ixekizumab Improves Psoriatic Arthritis Pain, Fatigue
Patients report sustained improvements in pain and fatigue from taking ixekizumab every 2 or 4 weeks over 3 years.
RA Patients With ACPA or RF Positivity Less Likely to Discontinue Abatacept
The findings are important to understand treatment persistence and switch patterns in rheumatoid arthritis patients with poor prognostic factors in a real-world setting.
Gut Microbiome Hints at Lupus Nephritis Disease Activity
Dr. Gregg Silverman said identification of Ruminococcus gnavus could allow earlier diagnosis of lupus nephritis.
Tanezumab Outperforms Placebo, Tramadol in Improving Chronic Back Pain
Findings suggest 5-10 mg of tanezumab significantly improve pain versus placebo in patients with chronic low back pain.
Upadacitinib Improves Rheumatoid Arthritis Pain, Function Over Adalimumab
The results highlight a significant improvement in rheumatoid arthritis signs and symptoms for those who used upadacitinib over placebo and adalimumab.
Upadacitinib Reduces Key Biomarker for Rheumatoid Arthritis
In a study presented at EULAR, investigators find 14-3-3η baseline levels did not correlate with baseline mTSS.
Guselkumab Effective Treating Dactylitis and Enthesitis
In both DISCOVER trials, investigators find guselkumab effective against active psoriatic arthritis domains.
Apremilast Effective Treating Genital Ulcers Linked to Active Behcet's Syndrome
The treatment has already proven to reduce oral ulcers associated with Behcet’s syndrome.
Different Forms of Adalimumab Safe, Effective in RA Patients
Patients are unaffected by the switch from ADL-EU to ADL-PF.